cached image

Barry J. Hoffer

Affiliations: 
National Institute on Drug Abuse 
Area:
Pharmacology
Website:
http://www.drugabuse.gov/DIR/cell-neuro.html
Google:
"Barry Hoffer"
Mean distance: 12.89 (cluster 6)
 
SNBCP
Cross-listing: Chemistry Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Huang PS, Tsai PY, Yang LY, et al. (2021) 3,6'-Dithiopomalidomide Ameliorates Hippocampal Neurodegeneration, Microgliosis and Astrogliosis and Improves Cognitive Behaviors in Rats with a Moderate Traumatic Brain Injury. International Journal of Molecular Sciences. 22
Ho MH, Yen CH, Hsieh TH, et al. (2021) CCL5 via GPX1 activation protects hippocampal memory function after mild traumatic brain injury. Redox Biology. 46: 102067
Chen YH, Wu KJ, Hsieh W, et al. (2021) Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein. Genes. 12
Hsueh SC, Luo W, Tweedie D, et al. (2021) -Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge. Acs Pharmacology & Translational Science. 4: 980-1000
Wang V, Kuo TT, Huang EY, et al. (2021) Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's Disease. Acs Pharmacology & Translational Science. 4: 858-869
Ghiam MK, Patel SD, Hoffer A, et al. (2021) Drug Repurposing in the Treatment of Traumatic Brain Injury. Frontiers in Neuroscience. 15: 635483
Yu SJ, Chen S, Yang YY, et al. (2020) PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson's Disease. Frontiers in Neuroscience. 14: 785
Tweedie D, Karnati HK, Mullins R, et al. (2020) Time-dependent cytokine and chemokine changes in mouse cerebral cortex following a mild traumatic brain injury. Elife. 9
Lin CT, Lecca D, Yang LY, et al. (2020) 3,6'-Dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation. Elife. 9
Chen YH, Yu SJ, Wu KJ, et al. (2020) Downregulation of α-Synuclein Protein Levels by an Intracellular Single-Chain Antibody. Journal of Parkinson's Disease
See more...